* Equal contribution

2016

1. Müller UJ, Schuermann F, Dobrowolny H, Frodl T, Bogerts B, Mohr S, Steiner J. Assessment of pharmacological treatment quality: Comparison of symptom-triggered versus fixed-schedule alcohol withdrawal in clinical practice. Pharmacopsychiatry [in press].

2. Müller UJ, Sturm V, Voges J, Heinze HJ, Galazky I, Heldmann M, Frodl T, Steiner J, Bogerts B. Nucleus accumbens deep brain stimulation for alcohol addiction – safety and clinical long-term results of a pilot trial. Pharmacopsychiatry [in press].

3. Uhrig S, Hirth N, Broccoli L, von Wilmsdorff M, Bauer M, Sommer C, Zink M, Steiner J, Frodl T, Malchow B, Falkai P, Spanagel R, Hansson AC, Schmitt A. Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study. Schizophrenia Research [in press].

4. Bernstein HG, Hildebrandt J, Dobrowolny H, Steiner J, Bogerts B, Pahnke J. Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the medial habenula. Schizophrenia Research [in press].

5. Steiner J*, Brisch R*, Schiltz K, Dobrowolny H, Mawrin C, Krzyżanowska M, Bernstein HG, Jankowski Z, Braun K, Schmitt A, Bogerts B, Gos T. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: a post-mortem study. Schizophrenia Research [in press].

6. Falkai P*, Steiner J*, Malchow B, Shariati J, Knaus A, Bernstein HG, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitt A. Oligodendrocyte and interneuron density in hippocampal subfields in schizophrenia and association of oligodendrocyte number with cognitive deficits. Front Cell Neurosci [in press].

7. Cassoli JS, Iwata K, Steiner J, Guest PC, Turck CW, Nascimento JM, Martins-de-Souza D. Effect of MK-801 and clozapine on the proteome of cultured human oligodendrocytes. Front Cell Neurosci [in press].

8. Schuemberg K, Polyakova M, Steiner J, Schroeter ML. Serum S100B is related to illness duration and clinical symptoms in schizophrenia - A meta-regression analysis. Front Cell Neurosci [in press].

9. Krzyżanowska M, Steiner J, Karnecki K, Kaliszan M, Brisch R, Wiergowski M, Braun K, Jankowski Z, Gos T. Decreased ribosomal DNA transcription in dorsal raphe nucleus neurons differentiates between suicidal and non-suicidal death. Eur Arch Psychiatry Clin Neurosci [in press].

10. Chan MK, Cooper JD, Bot M, Steiner J, Penninx BW, Bahn S. Identification of an immune-neuroendocrine biomarker panel for detection of depression: A joint effects statistical approach. Neuroendocrinology [in press].

11. Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein HG, Steiner J, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitz C, Schmitt A. Decreased oligodendrocyte and neuron number in anterior hippocampal areas and the entire hippocampus in schizophrenia: A stereological post-mortem study. Schizophr Bull [in press].

12. Fernandes BS, Steiner J, Bernstein HG, Dodd S, Pasco JA, Dean OM, Nardin P, Gonçalves CA, Berk M. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry [in press].

13. Tomasik J, Schwarz E, Lago SG, Rothermundt M, Leweke FM, van Beveren NJ, Guest PC, Rahmoune H, Steiner J, Bahn S. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients. Brain Behav Immun. 2016 Feb;52:178-186.

14. Haenisch F, Cooper JD, Reif A, Kittel-Schneider S, Steiner J, Leweke FM, Rothermundt M, van Beveren NJ, Crespo-Facorro B, Niebuhr DW, Cowan DN, Weber NS, Yolken RH, Penninx BW, Bahn S. Towards a blood-based diagnostic panel for bipolar disorder. Brain Behav Immun. 2016 Feb;52:49-57.

15. Bernstein HG, Ortmann A, Dobrowolny H, Steiner J, Brisch R, Gos T, Bogerts B. Bilaterally reduced claustral volumes in schizophrenia and major depressive disorder: a morphometric postmortem study. Eur Arch Psychiatry Clin Neurosci. 2016 Feb;266(1):25-33.

16. Castillo-Gomez E, Kästner A, Steiner J, Schneider A, Hettling B, Poggi G, Ostehr K, Uhr M, Asif AR, Matzke M, Schmidt U, Pfander V, Hammer C, Schulz TF, Binder L, Stöcker W, Weber F, Ehrenreich H. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1. Ann Neurol. 2016 Jan;79(1):144-151.

2015

1. Martins-de-Souza D, Solari FA, Guest PC, Zahedi RP, Steiner J. Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response. NPJ Schizophrenia. 2015 Dec;15050 (7 pages).

2. Krzyżanowska M*, Steiner J*, Brisch R, Mawrin C, Busse S, Braun K, Jankowski Z, Bernstein HG, Bogerts B, Gos T. Ribosomal DNA transcription in dorsal raphe nucleus neurons is increased in residual schizophrenia compared to depressed patients with affective disorders. Psychiatry Res. 2015 Dec 15;230(2):233-241.

3. Müller UJ, Truebner K, Schiltz K, Kuhn J, Mawrin C, Dobrowolny H, Bernstein HG, Bogerts B, Steiner J. Postmortem volumetric analysis of the nucleus accumbens in male heroin addicts: implications for deep brain stimulation. Eur Arch Psychiatry Clin Neurosci. 2015 Dec;265(8):647-653.

4. Brisch R, Bielau H, Saniotis A, Wolf R, Bogerts B, Krell D, Steiner J, Braun K, Krzyżanowska M, Krzyżanowski M, Jankowski Z, Kaliszan M, Bernstein HG, Gos T. Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei. Front Cell Neurosci. 2015 Oct 29;9:393 (13 pages).

5. Busse S, Steiner J, Alter J, Dobrowolny H, Mawrin C, Bogerts B, Hartig R, Busse M. Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease. J Alzheimers Dis. 2015;47(1):177-184.
6. Bernstein HG1, Jäger K, Dobrowolny H, Steiner J, Keilhoff G, Bogerts B, Laube G. Possible sources and functions of L-homoarginine in the brain: review of the literature and own findings. Amino Acids. 2015 Sep;47(9):1729-1740.

7. Fernandes BS, Steiner J, Berk M, Molendijk ML, Gonzalez-Pinto A, Turck CW, Nardin P, Gonçalves CA. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol Psychiatry. 2015 Sep;20(9):1108-1119.

8. Bernstein HG, Meyer-Lotz G, Dobrowolny H, Bannier J, Steiner J, Walter M, Bogerts B. Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder. Front Cell Neurosci. 2015 Aug 10;9:273 (12 pages).

9. Chan MK, Krebs MO, Cox D, Guest PC, Yolken RH, Rahmoune H, Rothermundt M, Steiner J, Leweke FM, van Beveren NJ, Niebuhr DW, Weber NS, Cowan DN, Suarez-Pinilla P, Crespo-Facorro B, Mam-Lam-Fook C, Bourgin J, Wenstrup RJ, Kaldate RR, Cooper JD, Bahn S. Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset. Transl Psychiatry. 2015 Jul 14;5:e601 (10 pages).

10. Bot M, Chan MK, Jansen R, Lamers F, Vogelzangs N, Steiner J, Leweke FM, Rothermundt M, Cooper J, Bahn S, Penninx BW. Serum proteomic profiling of major depressive disorder. Transl Psychiatry. 2015 Jul 14;5:e599 (9 pages).

11. Malchow B, Strocka S, Frank F, Bernstein HG, Steiner J, Schneider-Axmann T, Hasan A, Reich-Erkelenz D, Schmitz C, Bogerts B, Falkai P, Schmitt A. Stereological investigation of the posterior hippocampus in affective disorders. J Neural Transm. 2015 Jul;122(7):1019-1033.

12. Bernstein HG, Lindquist JA, Keilhoff G, Dobrowolny H, Brandt S, Steiner J, Bogerts B, Mertens PR. Differential distribution of Y-box-binding protein 1 and cold shock domain protein A in developing and adult human brain. Brain Struct Funct. 2015 Jul;220(4):2235-2245.

13. Busse M, Busse S, Myint AM, Gos T, Dobrowolny H, Müller UJ, Bogerts B, Bernstein HG, Steiner J. Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? Eur Arch Psychiatry Clin Neurosci. 2015 Jun;265(4):321-329.

14. Busse S*, Steiner J*, Glorius S, Dobrowolny H, Greiner-Bohl S, Mawrin C, Bommhardt U, Hartig R, Bogerts B, Busse M. VGF expression by T lymphocytes in patients with Alzheimer's disease. Oncotarget. 2015 Jun 20;6(17):14843-14851.

15. Zerche M, Weissenborn K, Ott C, Dere E, Asif AR, Worthmann H, Hassouna I, Rentzsch K, Tryc AB, Dahm L, Steiner J, Binder L, Wiltfang J, Sirén AL, Stöcker W, Ehrenreich H. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke. Stroke. 2015 May;46(5):1180-1186.

16. Bernstein HG, Dobrowolny H, Trübner K, Steiner J, Bogerts B, Hoffmann W. Differential regional and cellular distribution of TFF3 peptide in the human brain. Amino Acids. 2015 May;47(5):1053-1063.

17. Guest PC, Iwata K, Kato TA, Steiner J, Schmitt A, Turck CW, Martins-de-Souza D. MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. Front Cell Neurosci. 2015 May 12;9:180 (10 pages).

18. Krzyzanowska M*, Steiner J*, Brisch R, Mawrin C, Busse S, Braun K, Jankowski Z, Bernstein HG, Bogerts B, Gos T. Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2015 Mar;265(2):117-126.

19. Schwarz E*, Steiner J*, Guest PC, Bogerts B, Bahn S. Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain. World J Biol Psychiatry. 2015 Jan;16(1):22-30.

 

2014

1. Steiner J, Martins-de-Souza D, Schiltz K, Sarnyai Z, Westphal S, Isermann B, Dobrowolny H, Turck CW, Bogerts B, Bernstein HG, Horvath TL, Schild L, Keilhoff G. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. Front Cell Neurosci. 2014 Nov 18;8:384 (11 pages).

2. Bernstein HG, Bannier J, Meyer-Lotz G,Steiner J, Keilhoff G, Dobrowolny H, Walter M, Bogerts B. Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization. J Chem Neuroanat. 2014 Nov;61-62:33-50.

3. Stelzhammer V, Haenisch F, Chan MK, Cooper JD,Steiner J, Steeb H, Martins-de-Souza D, Rahmoune H, Guest PC, Bahn S. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients. Int J Neuropsychopharmacol. 2014 Oct;17(10):1599-1608.

4. Gos T*, Myint AM*, Schiltz K, Meyer-Lotz G, Dobrowolny H, Busse S, Müller UJ, Mawrin C, Bernstein HG, Bogerts B,Steiner J. Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients. Brain Behav Immun. 2014 Oct;41:59-64.

5. Busse S*, Busse M*, Brix B, Probst C, Genz A, Bogerts B, Stoecker W,Steiner J. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. Eur Arch Psychiatry Clin Neurosci. 2014 Sep;264(6):545-550.

6. Müller UJ, Teegen B, Probst C, Bernstein HG, Busse S, Bogerts B, Schiltz K, Stoecker W,Steiner J. Absence of dopamine receptor serum autoantibodies in schizophrenia patients with an acute disease episode. Schizophr Res. 2014 Sep;158(1-3):272-274.

7. Dahm L*, Ott C*,Steiner J*, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stöcker W, Ehrenreich H. Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol. 2014 Jul;76(1):82-94.

8. Steiner J, Teegen B, Schiltz K, Bernstein HG, Stoecker W, Bogerts B. Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited. JAMA Psychiatry. 2014 Jul 1;71(7):838-839.

9. Schwarz E, van Beveren NJ, Ramsey J, Leweke FM, Rothermundt M, Bogerts B,Steiner J, Guest PC, Bahn S. Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways. Schizophr Bull. 2014 Jul;40(4):787-795.

10. Busse S*,Steiner J*, Micheel J, Dobrowolny H, Mawrin C, Krause TJ, Adamaszek M, Bogerts B, Bommhardt U, Hartig R, Busse M. Age-related increase of VGF-expression in T lymphocytes. Aging (Albany NY). 2014 Jun;6(6):440-453.

11. Steiner J*, Schmitt A*, Schroeter ML, Bogerts B, Falkai P, Turck CW, Martins-de-Souza D. S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264(4):311-316.

12. de Witte L*, Tomasik J*, Schwarz E, Guest PC, Rahmoune H,Steiner J, Rothermundt M, Leweke FM, van Beveren NJ, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res. 2014 Apr;154(1-3):23-29.

13. Bernstein HG,Steiner J, Dobrowolny H, Bogerts B. ZNF804A Protein Is Widely Expressed in Human Brain Neurons: Possible implications on normal brain structure and pathomorphologic changes in schizophrenia. Schizophr Bull. 2014 May;40(3):499-500.

14. Bernstein HG, Trübner K, Krebs P, Dobrowolny H, Bielau H,Steiner J, Bogerts B. Increased densities of nitric oxide synthase expressing neurons in the temporal cortex and the hypothalamic paraventricular nucleus of polytoxicomanic heroin overdose victims: Possible implications for heroin neurotoxicity. Acta Histochem. 2014 Jan;116(1):182-190.

15. Steiner J, Bernstein HG, Schiltz K, Haase T, Meyer-Lotz G, Dobrowolny H, Müller UJ, Martins-de-Souza D, Borucki K, Schroeter ML, Isermann B, Bogerts B, Westphal S. Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response. Psychoneuroendocrinology. 2014 Jan;39:33-38.

16. Steiner J, Gos T, Handerer I, Bernstein HG, Bogerts B. Ist eine Aktivierung von Mikrogliazellen von pathophysiologischer Bedeutung? Patienten mit Schizophrenie, Depression oder Suizidalität. Nervenheilkunde. 2014 Dec;33(11):790-796.

17. Müller UJ, Bogerts B, Voges J, Galazky I, Kohl S, Heinze HJ, Kuhn J,Steiner J. Tiefe Hirnstimulation in der Psychiatrie: Ethische Aspekte. Psychiatr Prax. 2014 Jul;41 Suppl 1:S38-43.

18. Fernandes BS, Berk M, Turck CW,Steiner J, Gonçalves CA. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry. 2014 Jul;19(7):750-751.

19. Schroeter ML,Steiner J, Schönknecht P, Mueller K. Further evidence for a role of S100B in mood disorders: A human gene expression mega-analysis. J Psychiatr Res. 2014 Jun;53:84-86.

20. Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG,Steiner J, Bogerts B, Braun K, Jankowski Z, Kumaratilake J, Henneberg M, Gos T. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014 May 19;5:47 (11 pages).

21. Steiner J, Bernstein HG, Schiltz K, Müller UJ, Westphal S, Drexhage HA, Bogerts B. Immune system and glucose metabolism interaction in schizophrenia: A chicken-egg dilemma. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:287-294.

22. Bernstein HG,Steiner J, Bogerts B, Stricker R, Reiser G. Nardilysin, ADAM10, and Alzheimer's disease: of mice and men. Neurobiol Aging. 2014 Mar;35(3):e1.

 

2013

1. Iwata K, Café-Mendes CC, Schmitt A,Steiner J, Manabe T, Matsuzaki H, Falkai P, Turck CW, Martins-de-Souza D. The human oligodendrocyte proteome. Proteomics. 2013 Dec;13(23-24):3548-53.

2. Bernstein HG, Kirches E, Bogerts B, Lendeckel U, Keilhoff G, Zempeltzi M,Steiner J, Tenbrock K, Dobrowolny H, Kyttaris VC, Mawrin C. Wide distribution of CREM immunoreactivity in adult and fetal human brain, with an increased expression in dentate gyrus neurons of Alzheimer's as compared to normal aging brains. Amino Acids. 2013 Dec;45(6):1373-83.

3. Bernstein HG, Tausch A, Wagner R,Steiner J, Seeleke P, Walter M, Dobrowolny H, Bogerts B. Disruption of Glutamate-Glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase. CNS Neurol Disord Drug Targets. 2013 Nov;12(7):900-913.

4. Bielau H, Brisch R, Gos T, Dobrowolny H, Baumann B, Mawrin C, Kreutzmann P, Bernstein HG, Bogerts B,Steiner J. Volumetric analysis of the hypothalamus, amygdala and hippocampus in non-suicidal and suicidal mood disorder patients – a post-mortem study. CNS Neurol Disord Drug Targets. 2013 Nov;12(7):914-920.

5. Gos T*,Steiner J*, Jankowski Z, Bogerts B. Impairment of neuronal activity in depression assessed postmortem: the dominant impact of suicide. CNS Neurol Disord Drug Targets. 2013 Nov;12(7):930-935.

6.Steiner J, Gos T, Bogerts B, Bielau H, Drexhage HA, Bernstein HG. Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior. CNS Neurol Disord Drug Targets. 2013 Nov;12(7):971-979.

7. Ramsey JM, Schwarz E, Guest PC, van Beveren NJM, Leweke FM, Rothermundt M, Bogerts B,Steiner J, Bahn S. Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients. PLoS ONE. 2013 Nov;8(11): e78729 (8 pages).

8. Gos T, Schroeter ML, Lessel W, Bernstein HG, Dobrowolny H, Schiltz K, Bogerts B,Steiner J. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. J Psychiatr Res. 2013 Nov;47(11):1694-1649.

9. Gos T*,Steiner J*, Krell D, Bielau H, Mawrin C, Krzyżanowski M, Brisch R, Pieśniak D, Bernstein HG, Jankowski Z, Braun K, Bogerts B. Ribosomal DNA transcription in the anterior cingulate cortex is decreased in unipolar but not bipolar I depression. Psychiatry Res. 2013 Nov 30;210(1):338-345.

10. Schroeter ML, Sacher J,Steiner J, Schoenknecht P, Mueller K. Serum S100B represents a new biomarker for mood disorders. Curr Drug Targ. 2013 Oct;14(11):1237-1248.

11. Yang S, Yang Z, Fischer K, Zhong K, Stadler J, Godenschweger F,Steiner J, Heinze HJ, Bernstein HG, Bogerts B, Mawrin C, Reutens DC, Speck O, Walter M. Integration of ultra-high field MRI and histology for connectome based research of brain disorders. Front Neuroanat. 2013 Sep 27;7:31 (10 pages).

12.Drexhage RC, de Picker L, Beumer W, Gibney SM,Steiner J, Birkenhäger TK, Versnel MA, Drexhage HA. De immuuntheorie van psychiatrische ziekten: een sleutelrol voor geactiveerde mononucleaire fagocyten. Psyfar. 2013 Sep 12;3:2 (6 pages).

13.Müller S, Lendeckel U, Dobrowolny H,Steiner J, Bogerts B, Bernstein HG. Some notes on insulin-regulated aminopeptidase in depression. Int J Neuropsychopharmacol. 2013 Sep;16(8):1877-1878.

14.Bernstein HG, Dobrowolny H,Steiner J, Bogerts B. Heart failure--an identified but largely ignored source of errors in postmortem brain volume studies. J Card Fail. 2013 Aug;19(8):600.

15.Bernstein HG, Stricker R, Dobrowolny H,Steiner J, Bogerts B, Trübner K, Reiser G. Nardilysin in human brain diseases: both friend and foe. Amino Acids. 2013 Aug;45(2):269-278.

16.Mosebach J, Keilhoff G, Gos T, Schiltz K, Schoeneck L, Dobrowolny H, Mawrin C, Müller S, Schroeter ML, Bernstein HG, Bogerts B,Steiner J. Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: A regenerative attempt to compensate oligodendrocyte loss? J Psychiatr Res. 2013 Aug;47(8):1069-1079.

17.Osoba A, Hänggi J, Li M, Horn DI, Metzger C, Eckert U, Kaufmann J, Zierhut K,Steiner J, Schiltz K, Heinze HJ, Bogerts B, Walter M. Disease severity is correlated to tract specific changes of fractional anisotropy in MD and CM thalamus-A DTI study in major depressive disorder. J Affect Disord. 2013 Jul;149(1-3):116-128.

18.Bernstein HG, Dobrowolny H, Schott BH, Gorny X, Becker V,Steiner J, Seidenbecher CI, Bogerts B. Increased density of AKAP5-expressing neurons in the anterior cingulate cortex of subjects with bipolar disorder. J Psychiatr Res. 2013 Jun;47(6):699-705.

19.Zierhut KC, Schulte-Kemna A, Kaufmann J, Steiner J, Bogerts B, Schiltz K. Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia. Cortex. 2013 Apr;49(4):1063-1072.

20.Müller UJ, Voges J,Steiner J, Galazky I, Heinze HJ, Möller M, Pisapia J, Halpern C, Caplan A, Bogerts B, Kuhn J. Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Ann N Y Acad Sci. 2013 Apr;1282(1):119-128.

21.Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W. Increased prevalence of diverse N-Methyl-D-Aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-Methyl-D-Aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013 Mar 1;70(3):271-278.

22.Zierhut KC, Graßmann R, Kaufmann J,Steiner J, Bogerts B, Schiltz K. Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia. Brain. 2013 Mar;136(Pt 3):804-814.

23.Bernstein HG, Stricker R, Zschiebsch K, Müller S, Dobrowolny H,Steiner J, Bogerts B, Reiser G. Decreased expression of nardilysin in SH-SY5Y cells under ethanol stress and reduced density of nardilysin-expressing neurons in brains of alcoholics. J Psychiatr Res. 2013 Mar;47(3):343-349.

24.Jäger K, Wolf S, Dobrowolny H,Steiner J, Nave H, Maronde E, Bogerts B, Bernstein HG. Differential topochemistry of three cationic amino acid transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brain. Amino Acids. 2013 Feb;44(2):423-433.

25.Steiner J, Bernstein HG, Bogerts B, Gonçalves CA. Potential roles of S100B in schizophrenia. Rev psiquiatr clín. 2013 Mar;40(1):35-40.

26.Bernstein HG, Keilhoff G, Lendeckel U,Steiner J, Bogerts B. Concerning HB-EGF brain levels in Schizophrenia: cellular distribution of putative Sheddases may matter. CNS Neurosci Ther. 2013 Feb;19(2):136-137.

 


2012

1. Steiner J, Bogerts B.
Schizophrene Störungen. In: Handbuch der Psychopharmakotherapie, 2nd Edition, 2012; pp 297-314. Edited by Gründer J and Benkert O. Springer, Berlin / Heidelberg / New York.

2. Ramsey JM, Schwarz E, Guest PC, van Beveren NJM, Leweke FM, Rothermundt M, Bogerts B,Steiner J, Ruta L, Baron-Cohen S, Bahn S.
Molecular sex differences in human serum. PLoS ONE. 2012;7(12)

3. Bernstein H-, Smalla K-, Dürrschmidt D, Keilhoff G, Dobrowolny H,Steiner J, Schmitt A, Kreutz MR, Bogerts B. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. NeuroMolecular Medicine. 2012;14(4):270-80.

4. Eckert U, Metzger CD, Buchmann JE, Kaufmann J, Osoba A, Li M, Safron A, Liao W,Steiner J, Bogerts B, Walter M.
Preferential networks of the mediodorsal nucleus and centromedian-parafascicular complex of the thalamus-A DTI tractography study. Hum Brain Mapp. 2012;33(11):2627-37.

5. Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, Mawrin C, Schmitt A, Jordan W, Müller UJ, Bernstein H-, Bogerts B,Steiner J.
Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations? Brain Behav Immun. 2012;26(8):1273-9.

6. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC,Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA.
The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes. J Leukoc Biol. 2012;92(5):959-75.

7. Steiner J, Bogerts B, Sarnyai Z, Walter M, Gos T, Bernstein H-, Myint A-.
Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired bloodbrain barrier integrity. World Journal of Biological Psychiatry. 2012;13(7):482-92.

8. Streitbürger D-, Arelin K, Kratzsch J, Thiery J,Steiner J, Villringer A, Mueller K, Schroeter ML.
Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - A combined serum, gene expression and MRI study. PLoS ONE. 2012;7(8)

9. Busse S, Bernstein H-, Busse M, Bielau H, Brisch R, Mawrin C, Müller S, Zoltán Sarnyai, Gos T, Bogerts B,Steiner J.
Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: A potential link to impaired growth factor signaling and energy homeostasis. Eur Arch Psychiatry Clin Neurosci. 2012;262(5):365-74.

10. Bielau H, Brisch R, Bernard-Mittelstaedt J, Dobrowolny H, Gos T, Baumann B, Mawrin C, Bernstein H-, Bogerts B,Steiner J. Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Res. 2012;1459:91-9.

11. Brisch R, Bielau H, Gos T,Steiner J, Jankowski Z, Wolf R, Bogerts B, Bernstein H-.
Review: Involvement of the cavum septi pellucidi and the fornix in the neuropathology of schizophrenia and affective disorders. Current Psychiatry Reviews. 2012;8(2):161-7.

12. Steiner J, Westphal S, Schroeter ML, Schiltz K, Jordan W, Müller UJ, Bernstein H-, Bogerts B, Schmidt RE, Jacobs R.
Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels. Brain Behav Immun. 2012;26(4):564-7.

13. Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, Van Beveren NJM, Baron-Cohen S,Steiner J, Torrey FE, Yolken RH, Bahn S.
Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012;17(5):494-502.

14. Gos T,Steiner J, Bielau H, Dobrowolny H, Günther K, Mawrin C, Krzyzanowski M, Hauser R, Brisch R, Bernstein H-, Jankowski Z, Braun K, Bogerts B.
Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. Eur Arch Psychiatry Clin Neurosci. 2012:1-9.

15. Schwarz E, Guest PC,Steiner J, Bogerts B, Bahn S.
Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Translational Psychiatry. 2012;2

16. Bernstein H-, Klix M, Dobrowolny H, Brisch R,Steiner J, Bielau H, Gos T, Bogerts B.
A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders. Eur Arch Psychiatry Clin Neurosci. 2012:1-10.

17. Bernstein H-, Stich C, Jäger K, Dobrowolny H, Wick M,Steiner J, Veh R, Bogerts B, Laube G.
Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology. 2012;62(1):237-46.


2011

1. Bernstein H-, Lendeckel U,Steiner J, Bogerts B .
Do elevated glucocorticoids contribute to reduced cerebral expression of insulin-degrading enzyme in schizophrenia? J Psychiatr Res. 2011;45(12):1655-6.

2. Gos T, Bogerts B,Steiner J .
Neuronal activity patterns in depression assessed post mortem - which impacts have suicidality and unipolar-bipolar dichotomy? Nervenheilkunde. 2011;30(11):909-13.

3. Walter M, Horn DI, Bogerts B,Steiner J.
Aberrant resting state mechanisms in major depression - evidence from histopathology and non invasive imaging reveal the importance of glial dysfunction. Nervenheilkunde. 2011;30(11):914-21.

4. Bernstein H-, Keilhoff G,Steiner J, Dobrowolny H, Bogerts B.
Nitric oxide and schizophrenia: Present knowledge and emerging concepts of therapy. CNS and Neurological Disorders - Drug Targets. 2011;10(7):792-807.

5. Schroeter ML,Steiner J, Mueller K.
Glial pathology is modified by age in mood disorders - A systematic meta-analysis of serum S100B in vivo studies. J Affect Disord. 2011;134(1-3):32-8.

6. Jordan W, Bleich S, Cohrs S, Von Einsiedel R, Falkai P, Großkopf V, Hauth I,Steiner J, Adler L.
Definition of the core area of medical services in the psychiatric- psychotherapeutic field the prerequisite for any delegation. Psychiatr Prax. 2011;38(SUPPL. 2):S8-S15.

7. Jordan W, Adler L, Bleich S, Von Einsiedel R, Falkai P, Großkopf V, Hauth I,Steiner J, Cohrs S.
Shortage of doctors in psychiatric hospitals providing for the future by reorganizing medical services. Psychiatr Prax. 2011;38(SUPPL. 2):S16-24.

8. Jordan W, Adler L, Bleich S, Cohrs S, Einsiedel RV, Falkai P, Großkopf V, Hauth I,Steiner J.
Legal aspects of delegation and reorganisation of medical services in the psychiatric field. Psychiatr Prax. 2011;38(SUPPL. 2):S1-7.

9. Steiner J, Sarnyai Z, Westphal S, Gos T, Bernstein H-, Bogerts B, Keilhoff G.
Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. Eur Arch Psychiatry Clin Neurosci. 2011;261(7):477-82.

10. Schmitt A, Schulenberg W, Bernstein H-,Steiner J, Schneider-Axmann T, Yeganeh-Doost P, Malchow B, Hasan A, Gruber O, Bogerts B, Falkai P.
Reduction of gyrification index in the cerebellar vermis in schizophrenia: A post-mortem study. World Journal of Biological Psychiatry. 2011;12(SUPPL. 1):99-103.

11. Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein H-, Sarnyai Z, Mawrin C, Brisch R, Bielau H, zu Schwabedissen LM, Bogerts B, Myint A-.
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? Journal of Neuroinflammation. 2011;8

12. Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M, van Beveren NJM, Spain M, Barnes A,Steiner J, Rahmoune H, Bahn S.
Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology. 2011;36(7):1092-6.

13. Steiner J, Marquardt N, Pauls I, Schiltz K, Rahmoune H, Bahn S, Bogerts B, Schmidt RE, Jacobs R.
Human CD8 + T cells and NK cells express and secrete S100B upon stimulation. Brain Behav Immun. 2011;25(6):1233-41.

14. Bernstein H-, Lendeckel U,Steiner J, Bogerts B.
Oestrogen downregulates BACE protein in human cell culture: What does this teach us about alzheimer's disease? Neurodegenerative Diseases. 2011;8(3):153-4.

15. Steiner J, Bogerts B, Schroeter ML, Bernstein H-.
S100B protein in neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine. 2011;49(3):409-24.

16. Schreiber S, Bernstein H-, Fendrich R, Stauch R, Ketzler B, Dobrowolny H,Steiner J, Schreiber F, Bogerts B.
Increased density of GAD65/67 immunoreactive neurons in the posterior subiculum and parahippocampal gyrus in treated patients with chronic schizophrenia. World Journal of Biological Psychiatry. 2011;12(1):57-65.

17. Brisch R, Bernstein H-, Dobrowolny H, Krell D, Stauch R, Trübner K,Steiner J, Ghabriel MN, Bielau H, Wolf R, Winter J, Kropf S, Gos T, Bogerts B.
A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: Reduced neuronal density in the lateral septal nucleus in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2011;261(1):47-58.


2010

1. Bernstein HG, Ernst TS, Lendeckel U, Dobrowolny H,Steiner J, Bogerts B.
What protects patients with schizophrenia from developing Alzheimer pathology? In: Brain protection in schizophrenia, mood and cognitive disorders, 1st Edition, 2010; pp 45-66. Edited by Ritsner MS. Springer, Berlin / Heidelberg / New York.

2.Farkas N, Lendeckel U, Dobrowolny H, Funke S,Steiner J, Keilhoff G, Schmitt A, Bogerts B, Bernstein H-.
Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World Journal of Biological Psychiatry. 2010;11(3):556-66.

3. Horn DI, Yu C,Steiner J, Buchmann J, Kaufmann J, Osoba A, Eckert U, Zierhut KC, Schiltz K, He H, Biswa B, Bogerts B, Walter M.
Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula. Frontiers in Systems Neuroscience. 2010;4

4. Gos T, Krell D, Bielau H,Steiner J, Mawrin C, Trübner K, Brisch R, Bernstein H-, Jankowski Z, Bogerts B.
Demonstration of disturbed activity of the lateral amygdaloid nucleus projection neurons in depressed patients by the AgNOR staining method. J Affect Disord. 2010;126(3):402-10.

5. Metzger CD, Eckert U,Steiner J, Sartorius A, Buchmann JE, Stadler J, Tempelmann C, Speck O, Bogerts B, Abler B, Walter M.
High field fMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Frontiers in Neuroanatomy. 2010(NOV)

6. Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K, Bahn S, Herberth M, Westphal S, Gos T, Walter M, Bernstein H-, Myint AM, Bogerts B.
Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur Arch Psychiatry Clin Neurosci. 2010;260(7):509-18.

7. Zierhut K, Bogerts B, Schott B, Fenker D, Walter M, Albrecht D,Steiner J, Schütze H, Northoff G, Düzel E, Schiltz K.
The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Research - Neuroimaging. 2010;183(3):187-94.

8. Steiner J, Myint AM, Schiltz K, Westphal S, Bernstein H-, Walter M, Schroeter ML, Schwarz MJ, Bogerts B.
S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovascular Psychiatry and Neurology. 2010

9. Schroeter ML, Abdul-Khaliq H, Sacher J,Steiner J, Blasig IE, Mueller K.
Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology. 2010

10. Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC, Rahmoune H, Pietsch S, Markus Leweke F, Rothermundt M,Steiner J, Koethe D, Kranaster L, Ohrmann P, Suslow T, Levin Y, Bogerts B, van Beveren N, McAllister G, Weber N, Niebuhr D, Cowan D, Yolken RH, Bahn S.
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomarker Insights. 2010;2010(5):39-47.

11. Steiner J, Schroeter ML, Schiltz K, Bernstein HG, Müller UJ, Richter-Landsberg C, Müller WE, Walter M, Gos T, Bogerts B, Keilhoff G.
Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience. 2010;167(4):1025-31.

12. Dürrschmidt D, Smalla K-, Kreutz MR, Dobrowolny H,Steiner J, Keilhoff G, Bogerts B, Bernstein H-.
Increased oligodendroglial expression of the cell proliferation?controlling protein prohibitin in schizophrenia. A hint for cell cycle abnormalities? Acta Clinica Croatica. 2010;49(SUPPL. 2):39-41.

13. Bernstein H-, Müller S,Steiner J, Farkas N, Bogerts B, Lendeckel U.
Association between paternal schizophrenia and low birthweight: ADAM12 may matter. Asian J Androl. 2010;12(3):453-4.

14. Farkas N, Lendeckel U, Dobrowolny H, Funke S,Steiner J, Keilhoff G, Schmitt A, Bogerts B, Bernstein H-.
Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World Journal of Biological Psychiatry. 2010;11(3):193-203.

15. Steiner J, Schiltz K, Walter M, Wunderlich MT, Keilhoff G, Brisch R, Bielau H, Bernstein H-, Bogerts B, Schroeter ML, Westphal S.
S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research. Psychoneuroendocrinology. 2010;35(2):321-4.

16. Bernstein H-, Heinemann A,Steiner J, Bogerts B.
Schizophrenia, sleep disturbances and the suprachiasmatic nucleus: Reduced nitric oxide synthase may matter. Med Hypotheses. 2010;74(2):397-8.

17. Kirches E,Steiner J, Schneider T, Vorwerk CK, Scherlach C, Holtkamp N, Keilhoff G, Eng C, Mawrin C.
Lhermitte-duclos disease caused by a novel germline PTEN mutation R173P in a patient presenting with psychosis: Scientific correspondence. Neuropathol Appl Neurobiol. 2010;36(1):86-9.

18. Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, Van Beveren JM, Rothermundt M, McAllister G, Leweke FM,Steiner J, Bahn S.
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic nave schizophrenia patients. Mol Psychiatry. 2010;15(2):118-9.

19. Steiner J, Walter M, Guest P, Myint AM, Schiltz K, Panteli B, Brauner M, Bernstein H-, Gos T, Herberth M, Schroeter ML, Schwarz MJ, Westphal S, Bahn S, Bogerts B.
Elevated S100B levels in schizophrenia are associated with insulin resistance. Mol Psychiatry. 2010;15(1):3-4.


2009

1. Bogerts B,Steiner J, Bernstein HG.
Brain abnormalities in schizophrenia. In: Schizophrenia, 2nd Edition, 2009; pp 87-104. Edited by Kasper S and Papadimitriou GN. Informa Healthcare, New York.

2. Gos T, Krell D, Bielau H,Steiner J, Mawrin C, Trübner K, Brisch R, Bernstein H-, Jankowski Z, Bogerts B.
Demonstration of disturbed activity of orbitofrontal pyramidal neurons in depressed patients by the AgNOR staining method. J Affect Disord. 2009;118(1-3):131-8.

3. Bernstein H-, Ernst T, Lendeckel U, Bukowska A, Ansorge S, Stauch R, Have ST,Steiner J, Dobrowolny H, Bogerts B.
Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. J Psychiatr Res. 2009;43(13):1095-105.

4. Bernstein H-,Steiner J, Bogerts B.
Glial cells in schizophrenia: Pathophysiological significance and possible consequences for therapy. Expert Review of Neurotherapeutics. 2009;9(7):1059-71.

5. Steiner J, Walter M, Wunderlich MT, Bernstein H-, Panteli B, Brauner M, Jacobs R, Gos T, Rothermundt M, Bogerts B.
A new pathophysiological aspect of S100B in schizophrenia: Potential regulation of S100B by its scavenger soluble RAGE. Biol Psychiatry. 2009;65(12):1107-10.

6. Brisch R, Bernstein H-, Krell D, Dobrowolny H, Bielau H,Steiner J, Gos T, Funke S, Stauch R, Knüppel S, Bogerts B.
Dopamine-glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia. Brain Res. 2009;1269:166-75.

7. Schroeter ML,Steiner J.
Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol Psychiatry. 2009;14(3):235-7.

8. Bernstein H-, Stricker R, Lendeckel U, Bertram I, Dobrowolny H,Steiner J, Bogerts B, Reiser G.
Reduced neuronal co-localisation of nardilysin and the putative α-secretases ADAM10 and ADAM17 in alzheimer's disease and down syndrome brains. Age. 2009;31(1):11-25.

9. Gos T, Günther K, Bielau H, Dobrowolny H, Mawrin C, Trübner K, Brisch R,Steiner J, Bernstein H-, Jankowski Z, Bogerts B.
Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. J Affect Disord. 2009;113(1-2):45-55.

10. Gos T, Krell D, Bielau H,Steiner J, Trübner K, Brisch R, Bernstein H-, Jankowski Z, Bogerts B.
Demonstration of disturbed activity of external globus pallidus projecting neurons in depressed patients by the AgNOR staining method. J Affect Disord. 2009;119(1-3):149-55.


2008

1. Steiner J, Bielau H, Bernstein HG, Bogerts B.
Neurobiologie der Suizidalität: Spielen immunologische Prozesse eine Rolle? In: Biogenese und Psychogenese, 1st Edition, 2008; pp 376-383. Edited by Marneros A and Roettig D. Roderer Verlag, Regensburg.

2. Bielau H,Steiner J, Bernstein HG, Bogerts B.
Pathohistologische Befunde bei affektiven Störungen. In: Biogenese und Psychogenese, 1st Edition, 2008; pp 369-375. Edited by Marneros A and Roettig D. Roderer Verlag, Regensburg.

3. Brisch R, Bernstein H-, Stauch R, Dobrowolny H, Krell D, Truebner K, Meyer-Lotz G, Bielau H,Steiner J, Kropf S, Gos T, Danos P, Bogerts B.
The volumes of the fornix in schizophrenia and affective disorders: A post-mortem study. Psychiatry Research - Neuroimaging. 2008;164(3):265-73.

4. Gos T, Krell D, Brisch R, Bielau H, Trübner K,Steiner J, Bernstein H-, Bogerts B.
Demonstration of decreased activity of dorsal raphe nucleus neurons in depressed suicidal patients by the AgNOR staining method. J Affect Disord. 2008;111(2-3):251-60.

5. Gos T, Krell D, Bielau H, Brisch R, Trübner K,Steiner J, Bernstein H-, Jankowski Z, Bogerts B.
Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients. Eur Arch Psychiatry Clin Neurosci. 2008;258(8):513-20.

6. Steiner J, Bernstein H-, Bielau H, Farkas N, Winter J, Dobrowolny H, Brisch R, Gos T, Mawrin C, Myint AM, Bogerts B.
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: A morphometric study. J Psychiatr Res. 2008;42(10):868-76.

7. Steiner J, Bernstein H-, Bogerts B, Gos T, Richter-Landsberg C, Wunderlich MT, Keilhoff G.
S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation. Neuroscience. 2008;154(2):496-503.

8. Bernstein H-, Lendeckel U, Dobrowolny H, Stauch R,Steiner J, Grecksch G, Becker A, Jirikowski GF, Bogerts B.
Beacon-like/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia. Psychoneuroendocrinology. 2008;33(3):340-51.

9. Bernstein H-, Lendeckel U, Bukowska A, Ansorge S, Ernst T, Stauch R, Trübner K,Steiner J, Dobrowolny H, Bogerts B.
Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary. J Chem Neuroanat. 2008;35(2):216-24.

10. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein H-, Bogerts B.
Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2008;42(2):151-7.


2007

1. Steiner J, Bernstein H-, Bielau H, Berndt A, Brisch R, Mawrin C, Keilhoff G, Bogerts B.
Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neuroscience. 2007;8

2. Steiner J, Bogerts B, Hoffmeyer D, Brinkers M.
Cenesthesia as a rare differential diagnosis of persistent idiopathic facial. Nervenarzt. 2007;78(2):198-201.

3. Bielau H,Steiner J, Mawrin C, Trübner K, Brisch R, Meyer-Lotz G, Brodhun M, Dobrowolny H, Baumann B, Gos T, Bernstein H-, Bogerts B.
Dysregulation of GABAergic neurotransmission in mood disorders: A postmortem study; 2007. 157 p.


2006

1. Steiner J, Bielau H, Bernstein H-, Bogerts B, Wunderlich MT.
Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. Journal of Neurology, Neurosurgery and Psychiatry. 2006;77(11):1284-7.

2. Steiner J, Mawrin C, Ziegeler A, Bielau H, Ullrich O, Bernstein H-, Bogerts B.
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006;112(3):305-16.

3. Steiner J, Zajontz H, Reiss S, Bogerts B.
Differential diagnosis of anorexia nervosa and depression. A case report of addison's disease in a female patient. Nervenarzt. 2006;77(3):338-42.